114 related articles for article (PubMed ID: 15499564)
1. Polypeptide conjugates comprising a beta-amyloid plaque-specific epitope as new vaccine structures against Alzheimer's disease.
Manea M; Mezö G; Hudecz F; Przybylski M
Biopolymers; 2004; 76(6):503-11. PubMed ID: 15499564
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, solution conformation, and antibody recognition of oligotuftsin-based conjugates containing a beta-amyloid(4-10) plaque-specific epitope.
Manea M; Hudecz F; Przybylski M; Mezõ G
Bioconjug Chem; 2005; 16(4):921-8. PubMed ID: 16029033
[TBL] [Abstract][Full Text] [Related]
3. Design, structural, and immuno-analytical properties of antigenic bioconjugates comprising a beta-amyloid-plaque specific epitope.
Manea M; Przybylski M; Hudecz F; Mezö G
Biopolymers; 2008; 90(2):94-104. PubMed ID: 18183582
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and comparison of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII.
Mezö G; de Oliveira E; Krikorian D; Feijlbrief M; Jakab A; Tsikaris V; Sakarellos C; Welling-Wester S; Andreu D; Hudecz F
Bioconjug Chem; 2003; 14(6):1260-9. PubMed ID: 14624643
[TBL] [Abstract][Full Text] [Related]
5. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
Meli G; Visintin M; Cannistraci I; Cattaneo A
J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
[TBL] [Abstract][Full Text] [Related]
6. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.
Bard F; Barbour R; Cannon C; Carretto R; Fox M; Games D; Guido T; Hoenow K; Hu K; Johnson-Wood K; Khan K; Kholodenko D; Lee C; Lee M; Motter R; Nguyen M; Reed A; Schenk D; Tang P; Vasquez N; Seubert P; Yednock T
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2023-8. PubMed ID: 12566568
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response.
Zou J; Yao Z; Zhang G; Wang H; Xu J; Yew DT; Forster EL
J Neurol Sci; 2008 Sep; 272(1-2):87-98. PubMed ID: 18571202
[TBL] [Abstract][Full Text] [Related]
8. Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer's disease vaccination.
Solomon B
Vaccine; 2005 Mar; 23(17-18):2327-30. PubMed ID: 15755621
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and therapeutic efficacy of phage-displayed beta-amyloid epitopes.
Esposito M; Luccarini I; Cicatiello V; De Falco D; Fiorentini A; Barba P; Casamenti F; Prisco A
Mol Immunol; 2008 Feb; 45(4):1056-62. PubMed ID: 17850871
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro T-cell immunogenicity of conjugates with dual specificity: attachment of epitope peptides of 16 and 38 kDa proteins from Mycobacterium tuberculosis to branched polypeptide.
Wilkinson KA; Vordermeier H; Wilkinson RJ; Ivanyi J; Hudecz F
Bioconjug Chem; 1998; 9(5):539-47. PubMed ID: 9736487
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
Geylis V; Steinitz M
Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
[TBL] [Abstract][Full Text] [Related]
12. Peptide based vaccine design: synthesis and immunological characterization of branched polypeptide conjugates comprising the 276-284 immunodominant epitope of HSV-1 glycoprotein D.
Mezo G; Dalmadi B; Mucsi I; Bosze S; Rajnavölgyl E; Hudecz F
J Pept Sci; 2002 Mar; 8(3):107-17. PubMed ID: 11931583
[TBL] [Abstract][Full Text] [Related]
13. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.
Chackerian B; Rangel M; Hunter Z; Peabody DS
Vaccine; 2006 Sep; 24(37-39):6321-31. PubMed ID: 16806604
[TBL] [Abstract][Full Text] [Related]
14. Towards Alzheimer's beta-amyloid vaccination.
Frenkel D; Solomon B
Biologicals; 2001; 29(3-4):243-7. PubMed ID: 11851323
[TBL] [Abstract][Full Text] [Related]
15. Antibody recognition and conformational flexibility of a plaque-specific beta-amyloid epitope modulated by non-native peptide flanking regions.
Manea M; Kalászi A; Mezo G; Horváti K; Bodor A; Horváth A; Farkas O; Perczel A; Przybylski M; Hudecz F
J Med Chem; 2008 Mar; 51(5):1150-61. PubMed ID: 18284185
[TBL] [Abstract][Full Text] [Related]
16. Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice.
Muhs A; Hickman DT; Pihlgren M; Chuard N; Giriens V; Meerschman C; van der Auwera I; van Leuven F; Sugawara M; Weingertner MC; Bechinger B; Greferath R; Kolonko N; Nagel-Steger L; Riesner D; Brady RO; Pfeifer A; Nicolau C
Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9810-5. PubMed ID: 17517595
[TBL] [Abstract][Full Text] [Related]
17. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
[TBL] [Abstract][Full Text] [Related]
18. Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model.
Matsuda J; Kaminaka K; Nozaki C
Biochem Biophys Res Commun; 2009 Apr; 382(1):149-52. PubMed ID: 19265678
[TBL] [Abstract][Full Text] [Related]
19. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
[TBL] [Abstract][Full Text] [Related]
20. Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies.
Lee M; Bard F; Johnson-Wood K; Lee C; Hu K; Griffith SG; Black RS; Schenk D; Seubert P
Ann Neurol; 2005 Sep; 58(3):430-5. PubMed ID: 16130106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
